Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
2003 1
2004 1
2012 1
2013 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Why do we need drugs to treat the patient with obesity?
Bray GA. Bray GA. Obesity (Silver Spring). 2013 May;21(5):893-9. doi: 10.1002/oby.20394. Obesity (Silver Spring). 2013. PMID: 23520198 Free article. Review.
Weight loss can reduce mortality and improve most of the detrimental health consequences of obesity. DESIGN AND METHODS: This paper was developed from two presentations to the US Food and Drug Administration (FDA), which has responsibility for reviewing and approvin …
Weight loss can reduce mortality and improve most of the detrimental health consequences of obesity. DESIGN AND METHODS: This …
Zonisamide for weight reduction in obese adults: a 1-year randomized controlled trial.
Gadde KM, Kopping MF, Wagner HR 2nd, Yonish GM, Allison DB, Bray GA. Gadde KM, et al. Among authors: bray ga. Arch Intern Med. 2012 Nov 12;172(20):1557-64. doi: 10.1001/2013.jamainternmed.99. Arch Intern Med. 2012. PMID: 23147455 Free PMC article. Clinical Trial.
BACKGROUND: Obese individuals who have failed to achieve adequate weight loss with lifestyle changes have limited nonsurgical therapeutic options. We evaluated the efficacy and tolerability of zonisamide, an antiepileptic drug, for enhancing weight loss in obese pat …
BACKGROUND: Obese individuals who have failed to achieve adequate weight loss with lifestyle changes have limited nonsurgical therape …
Medical consequences of obesity.
Bray GA. Bray GA. J Clin Endocrinol Metab. 2004 Jun;89(6):2583-9. doi: 10.1210/jc.2004-0535. J Clin Endocrinol Metab. 2004. PMID: 15181027 Review.
This concept of the pathogenesis of obesity as a disease allows an easy division of disadvantages of obesity into those produced by the mass of fat and those produced by the metabolic effects of fat cells. ...The strong association of increased fat, especially visce …
This concept of the pathogenesis of obesity as a disease allows an easy division of disadvantages of obesity into those produc …
Risks of obesity.
Bray GA. Bray GA. Endocrinol Metab Clin North Am. 2003 Dec;32(4):787-804, viii. doi: 10.1016/s0889-8529(03)00067-7. Endocrinol Metab Clin North Am. 2003. PMID: 14711062 Review.
Obesity is a chronic disease caused by an imbalance between the energy ingested in food and the energy expended. ...The spectrum of medical, social, and psychologic disabilities includes a range of medical and behavioral problems....
Obesity is a chronic disease caused by an imbalance between the energy ingested in food and the energy expended. ...The spectrum of …
Intestinal bypass for obesity a summary and perspective.
Bray GA, Benfield JR. Bray GA, et al. Am J Clin Nutr. 1977 Jan;30(1):121-7. doi: 10.1093/ajcn/30.1.121. Am J Clin Nutr. 1977. PMID: 831434
The benefits of this treatment are permanent weight loss, improved psychosocial function, and a reduction in medical morbidity. The potential risks consist of mortality, a variety of postoperative complications, liver failure, renal stones, and the consequences of b …
The benefits of this treatment are permanent weight loss, improved psychosocial function, and a reduction in medical morbidity. The p …